Page last updated: 2024-09-05

lu 135252 and Cirrhosis

lu 135252 has been researched along with Cirrhosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dieterich, M; Gögebakan, O; Kossmehl, P; Kreutz, R; Rothermund, L; Vetter, R; Yagil, C; Yagil, Y1
Arck, PC; Godes, M; Herzfeld, S; Hocher, B; Kalk, P; Mach, A; Nafz, B; Neumayer, HH; Slowinski, T; Wiesner, D1
Amann, K; El-Shakmak, A; Gross, ML; Hansen, A; Heiss, N; Münter, K; Ritz, E; Szabo, A; Weckbach, M1
Angelini, A; Basso, C; Della Barbera, M; Iliceto, S; Kirchengast, M; Thiene, G1

Other Studies

4 other study(ies) available for lu 135252 and Cirrhosis

ArticleYear
Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
    Circulation, 2002, Oct-29, Volume: 106, Issue:18

    Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium-Binding Proteins; Calcium-Transporting ATPases; Desoxycorticosterone; Disease Models, Animal; Endothelin Receptor Antagonists; Fibrosis; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium Chloride; Ventricular Dysfunction, Left

2002
ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.
    Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:2

    Topics: Animals; Disease Progression; Endothelin Receptor Antagonists; Fibrosis; Kidney; Kidney Tubules; Male; Organ Size; Phenylpropionates; Polycystic Kidney Diseases; Propionates; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Renal Circulation

2003
ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.
    Diabetologia, 2004, Volume: 47, Issue:2

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arterioles; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Collagen Type IV; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Gene Expression; Heart; Immunohistochemistry; In Situ Hybridization; Indoles; Male; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Transforming Growth Factor beta

2004
Endothelin A-receptor antagonist administration immediately after experimental myocardial infarction with reperfusion does not affect scar healing in dogs.
    Cardiovascular research, 2002, Volume: 55, Issue:1

    Topics: Administration, Oral; Analysis of Variance; Animals; Dogs; Endothelin Receptor Antagonists; Fibrosis; Image Processing, Computer-Assisted; Immunohistochemistry; Injections, Intravenous; Male; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Transforming Growth Factor beta

2002